PTSD News

Service members with combat-related concussions demonstrated an evolution, rather than a resolution, of symptoms during a 5-year period, including selective worsening of cognitive function, according to findings published in Neurology.

A significant number of individuals report using cannabis to treat psychiatric and physical challenges, yet the evidence remains mixed on its efficacy, according to a presenter at the NEI Max virtual conference.

Network connectivity in the brain may shed light on trauma-related dissociative symptoms and symptom severity, according to results of an intrinsic network connectivity analysis published in American Journal of Psychiatry.

Augmentation of selective serotonin or serotonin-noradrenaline reuptake inhibitors with riluzole may improve PTSD hyperarousal symptoms, according to study results published in Journal of Clinical Psychiatry.

Mirtazapine monotherapy did not appear efficacious for treating PTSD, according to results of a randomized, placebo-controlled trial published in Journal of Clinical Psychiatry.

Routine mental health screening of police officers may be warranted in law enforcement agencies, according to results of a survey study published in JAMA Network Open.

Venlafaxine may be superior vs. other agents to achieve acute-phase remission for DSM-5 PTSD, according to study results published in Journal of Clinical Psychiatry.

The National Alliance on Mental Illness has designated this week as Mental Illness Awareness Week.

Specific interventions may mitigate PTSD symptoms among mass disaster first responders, according to results of a prospective cohort study published in JAMA Network Open.

Positive results on the Primary Care-Posttraumatic Stress Disorder Screen were associated with an increased risk for suicide mortality among veterans, according to study results published in JAMA Network Open.